{"title":"基于肠道菌群及临床病理参数的早期结直肠癌内镜下粘膜下夹层nomogram模型的构建与验证","authors":"Wenpeng Han, Yanyan Liu, Bo Zhang, Jing Liu, Mingxia Sun, Hongqing Zhuo","doi":"10.3389/fmed.2025.1604257","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the prognostic factors of endoscopic submucosal dissection (ESD) in early colorectal cancer patients and to develop a predictive model for assessing prognostic risk.</p><p><strong>Methods: </strong>We retrospectively analyzed the data of 126 patients with early colorectal cancer who underwent ESD treatment at our hospital from February 2022 to February 2024. All cases were randomly divided into the training set (88 cases) and the verification set (38 cases) in a ratio of 7:3. According to the prognosis of patients, they were divided into good prognosis group and bad prognosis group. Within the training set, multivariate Logistic regression analysis was used to identify the independent risk factors affecting the prognosis of ESD treatment and a nomogram prediction model was constructed. The validity of the model prediction was assessed by plotting the receiver operating characteristic (ROC) curve and the calibration curve, and the results were verified in the validation set. The clinical application value of Decision Curve Analysis (DCA) was explored.</p><p><strong>Results: </strong>Among the 126 patients, 33 cases (26.19%) had poor prognosis after ESD treatment. Logistic analysis showed that tumor size, lymph node metastasis, preoperative serum CEA level, Bacteroides abundance and Enterococcus abundance were the independent risk factors for poor prognosis of ESD treatment (<i>p</i> < 0.05). The nomogram model achieved C-index values of 0.898 (training set) and 0.926 (validation set), with mean absolute errors of 0.101 and 0.066, respectively. In the Hosmer-Lemeshow test, the <i>χ</i> values for the training and validation sets were 8.143(<i>p</i> = 0.419) and 10.591(<i>p</i> = 0.226), respectively. The ROC curves show AUC values of 0.897(95% CI 0.795-0.998) and 0.917(95% CI 0.752-1.000) for the training and validation sets, respectively, and a combination of sensitivity and specificity of 0.870 and 0.938, respectively, and 0.895 and 0.857, respectively.</p><p><strong>Conclusion: </strong>The nomogram prediction model based on the intestinal flora and clinical pathological parameters of patients with early colorectal cancer has high accuracy and calibration degree, which can provide a key reference for formulating individualized treatment plan in clinical and evaluating the prognosis of patients.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1604257"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162587/pdf/","citationCount":"0","resultStr":"{\"title\":\"Construction and validation of nomogram model for endoscopic submucosal dissection in patients with early colorectal cancer based on intestinal microflora and clinical pathological parameters.\",\"authors\":\"Wenpeng Han, Yanyan Liu, Bo Zhang, Jing Liu, Mingxia Sun, Hongqing Zhuo\",\"doi\":\"10.3389/fmed.2025.1604257\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study aimed to investigate the prognostic factors of endoscopic submucosal dissection (ESD) in early colorectal cancer patients and to develop a predictive model for assessing prognostic risk.</p><p><strong>Methods: </strong>We retrospectively analyzed the data of 126 patients with early colorectal cancer who underwent ESD treatment at our hospital from February 2022 to February 2024. All cases were randomly divided into the training set (88 cases) and the verification set (38 cases) in a ratio of 7:3. According to the prognosis of patients, they were divided into good prognosis group and bad prognosis group. Within the training set, multivariate Logistic regression analysis was used to identify the independent risk factors affecting the prognosis of ESD treatment and a nomogram prediction model was constructed. The validity of the model prediction was assessed by plotting the receiver operating characteristic (ROC) curve and the calibration curve, and the results were verified in the validation set. The clinical application value of Decision Curve Analysis (DCA) was explored.</p><p><strong>Results: </strong>Among the 126 patients, 33 cases (26.19%) had poor prognosis after ESD treatment. Logistic analysis showed that tumor size, lymph node metastasis, preoperative serum CEA level, Bacteroides abundance and Enterococcus abundance were the independent risk factors for poor prognosis of ESD treatment (<i>p</i> < 0.05). The nomogram model achieved C-index values of 0.898 (training set) and 0.926 (validation set), with mean absolute errors of 0.101 and 0.066, respectively. In the Hosmer-Lemeshow test, the <i>χ</i> values for the training and validation sets were 8.143(<i>p</i> = 0.419) and 10.591(<i>p</i> = 0.226), respectively. The ROC curves show AUC values of 0.897(95% CI 0.795-0.998) and 0.917(95% CI 0.752-1.000) for the training and validation sets, respectively, and a combination of sensitivity and specificity of 0.870 and 0.938, respectively, and 0.895 and 0.857, respectively.</p><p><strong>Conclusion: </strong>The nomogram prediction model based on the intestinal flora and clinical pathological parameters of patients with early colorectal cancer has high accuracy and calibration degree, which can provide a key reference for formulating individualized treatment plan in clinical and evaluating the prognosis of patients.</p>\",\"PeriodicalId\":12488,\"journal\":{\"name\":\"Frontiers in Medicine\",\"volume\":\"12 \",\"pages\":\"1604257\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162587/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fmed.2025.1604257\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1604257","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨内镜下粘膜下剥离(ESD)对早期结直肠癌患者预后的影响因素,建立预后风险评估的预测模型。方法:回顾性分析2022年2月至2024年2月在我院接受ESD治疗的126例早期结直肠癌患者的资料。所有病例随机分为训练集(88例)和验证集(38例),比例为7:3。根据患者预后情况分为预后好组和预后差组。在训练集中,采用多因素Logistic回归分析,识别影响ESD治疗预后的独立危险因素,构建nomogram预测模型。通过绘制受试者工作特征(ROC)曲线和校准曲线来评估模型预测的有效性,并在验证集中对结果进行验证。探讨决策曲线分析(Decision Curve Analysis, DCA)的临床应用价值。结果:126例患者中,33例(26.19%)患者经ESD治疗后预后不良。Logistic分析显示,肿瘤大小、淋巴结转移、术前血清CEA水平、拟杆菌(Bacteroides)丰度和肠球菌(Enterococcus)丰度是影响ESD治疗预后不良的独立危险因素(p ),训练集和验证集的χ值分别为8.143(p = 0.419)和10.591(p = 0.226)。ROC曲线显示,训练集和验证集的AUC值分别为0.897(95% CI 0.795-0.998)和0.917(95% CI 0.752-1.000),灵敏度和特异性分别为0.870和0.938,0.895和0.857。结论:基于早期结直肠癌患者肠道菌群及临床病理参数的nomogram预测模型具有较高的准确性和校准度,可为临床制定个体化治疗方案及评估患者预后提供关键参考。
Construction and validation of nomogram model for endoscopic submucosal dissection in patients with early colorectal cancer based on intestinal microflora and clinical pathological parameters.
Objective: This study aimed to investigate the prognostic factors of endoscopic submucosal dissection (ESD) in early colorectal cancer patients and to develop a predictive model for assessing prognostic risk.
Methods: We retrospectively analyzed the data of 126 patients with early colorectal cancer who underwent ESD treatment at our hospital from February 2022 to February 2024. All cases were randomly divided into the training set (88 cases) and the verification set (38 cases) in a ratio of 7:3. According to the prognosis of patients, they were divided into good prognosis group and bad prognosis group. Within the training set, multivariate Logistic regression analysis was used to identify the independent risk factors affecting the prognosis of ESD treatment and a nomogram prediction model was constructed. The validity of the model prediction was assessed by plotting the receiver operating characteristic (ROC) curve and the calibration curve, and the results were verified in the validation set. The clinical application value of Decision Curve Analysis (DCA) was explored.
Results: Among the 126 patients, 33 cases (26.19%) had poor prognosis after ESD treatment. Logistic analysis showed that tumor size, lymph node metastasis, preoperative serum CEA level, Bacteroides abundance and Enterococcus abundance were the independent risk factors for poor prognosis of ESD treatment (p < 0.05). The nomogram model achieved C-index values of 0.898 (training set) and 0.926 (validation set), with mean absolute errors of 0.101 and 0.066, respectively. In the Hosmer-Lemeshow test, the χ values for the training and validation sets were 8.143(p = 0.419) and 10.591(p = 0.226), respectively. The ROC curves show AUC values of 0.897(95% CI 0.795-0.998) and 0.917(95% CI 0.752-1.000) for the training and validation sets, respectively, and a combination of sensitivity and specificity of 0.870 and 0.938, respectively, and 0.895 and 0.857, respectively.
Conclusion: The nomogram prediction model based on the intestinal flora and clinical pathological parameters of patients with early colorectal cancer has high accuracy and calibration degree, which can provide a key reference for formulating individualized treatment plan in clinical and evaluating the prognosis of patients.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world